3 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 1 | Unknown 1 |
Follow Overactive Bladder: new trials by email Literature Review of Overactive Bladder trials Research Report on Overactive Bladder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children Beta3-Agonists, Adrenergic, Anticholinergic drug, Solifenacin - Voiding Disorders, Overactive Bladder | Phase 1 / Phase 2 | Unknown | Mansoura University | 70 | 2022-02-01 | 2022-02-15 |
| Acupuncture Combined With Mirabegron in the Treatment of OAB 50 mg of mirabegron, acupuncture combined with mirabegron. - Overactive Bladder | Phase 1 | Unknown | The Affiliated Ganzhou Hospital of Nanchang University | 75 | 2021-12-01 | 2023-12-26 |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects DA-8010, Placebo - Overactive Bladder | Phase 1 | Unknown | Dong-A ST Co., Ltd. | 110 | 2016-06-01 | 2016-07-01 |
Urinary Bladder, Overactive (3) · Nocturia (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Lower Urinary Tract Symptoms (3) · Male Urogenital Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Urinary Bladder Diseases (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Urological Manifestations (3)
Adrenergic beta-3 Receptor Agonists (1) · Cholinergic Antagonists (1) · DA-8010 (1) · Solifenacin Succinate (1) · mirabegron (1)
Dong-A ST Co., Ltd. (1) · Mansoura University (1) · The Affiliated Ganzhou Hospital of Nanchang University (1)
China (1)
Islam Mansour, Mb ChB (1) · Jisu Song (1) · Xiaolin Deng, M.D. (1)